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Abstract
Background: The relationship between health-related quality of life (HRQoL) in people with Parkinson’s disease and
their caregivers is little understood and any effects on caregiver strain remain unclear. This paper examines these
relationships in an Australian sample.
Methods: Using the generic EuroQol (EQ-5D) and disease-specific Parkinson’s Disease Questionnaire-39 Item (PDQ-
39), HRQoL was evaluated in a sample of 97 people with PD and their caregivers. Caregiver strain was assessed
using the Modified Caregiver Strain Index. Associations were evaluated between: (i) caregiver and care-recipient
HRQoL; (ii) caregiver HRQoL and caregiver strain, and; (iii) between caregiver strain and care-recipient HRQoL.
Results: No statistically significant relationships were found between caregiver and care-recipient HRQoL, or
between caregiver HRQoL and caregiver strain. Although this Australian sample of caregivers experienced relatively
good HRQoL and moderately low strain, a significant correlation was found between HRQoL of people with PD and
caregiver strain (rho 0.43, p< .001).
Conclusion: Poor HRQoL in people with PD is associated with higher strain in caregivers. Therapy interventions
may target problems reported as most troublesome by people with PD, with potential to reduce strain on the
caregiver.
Background
Little is known about health-related quality of life
(HRQoL) in people with Parkinson’s disease (PD) and
their caregivers in Australia, or of the level of strain ex-
perienced by family caregivers of people with PD. This
paper investigates those issues and explores their
relationships.
Informal caregivers are estimated to provide some
$AUD30 billion support annually to people with disabil-
ities in Australia alone [1]. In the USA, this figure was
estimated to be as high as $US375 billion in 2007 [2]
and currently £119 billion in the UK [3]. In the case of
PD, family members and particularly spouses are usually
the primary caregivers [4,5]. Their support often enables
people with PD to remain at home despite increasing
disability, significantly reducing the costs associated with
a move to residential care [5,6]. Together with physical
assistance, family members can provide emotional and
practical support that helps maintain better quality of
life in the person with PD and may reduce morbidity
and mortality [7].
The vital support provided by informal caregivers is
not always without cost to the carers. There is a growing
body of literature detailing some of the negative sequelae
of PD on some caregivers’ lives. People providing care for
others with advanced PD have demonstrated an
increased incidence of depression [8,9], diminished qual-
ity of life [10], reduced economic circumstances [11,12]
and reduced physical [5] and mental health [5,10,13].
These and other factors brought about by stress and bur-
den can combine to cause increased levels of caregiver
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strain, which has been defined as “an enduring change
. . . in a caregiver’s fabric of well-being” [14].
With the importance of the care-giving role now
recognised, research attention is turning to the interplay
between caregiver and care-recipient. Understanding
which aspects of the care-recipient’s condition are most
likely to negatively affect caregiver wellbeing may enable
therapy interventions to be targeted to assist both pa-
tient and caregiver [15], such as addressing factors con-
tributing to decreased HRQoL.
Previous research has shown that quality of life in
people with PD and their caregivers is linked [5].
Health-related quality of life refers to facets of an indivi-
dual’s self-perceived well-being that are affected by dis-
ease or treatment [11], suggesting that it may respond to
appropriate therapy interventions. Parkinson’s disease is
known to reduce HRQoL in both people with PD [11]
and caregivers in general [7], yet much less is known
about the relationship between HRQoL in care-recipient
with PD and caregiver, or between caregiver HRQoL
and caregiver strain in those who care for individuals
with PD.
In this study, we report the HRQoL of an Australian
sample of people with PD and their caregivers, and
examine the level of strain in caregivers. A key aim was
to consider the relationship between HRQoL in people
with PD and their caregivers. Further aims were to de-
termine the associations between caregiver HRQoL and
caregiver strain; and HRQoL in PD and caregiver strain.
Methods
Study design
The study formed part of a larger clinical randomized
controlled trial that investigated the efficacy of two
physiotherapy programs relative to a control interven-
tion to reduce falls and improve mobility in people with
PD (see [16] for full details). Participants were drawn
from general medical practitioners, neurologists, Parkin-
son’s Victoria network and advertisements in local
papers. As part of their baseline assessments, partici-
pants with PD were asked if they had a significant other
person in their life whom they could designate as a care-
giver. The current study thus utilized a cross-sectional
design. The study design and content were approved by
the Human Research Ethics Committee of The Univer-
sity of Melbourne (HREC Number 0829579.2).
Participants
Participants with PD had to meet the criteria for the pri-
mary investigation which were: a diagnosis of idiopathic
PD; Hoehn and Yahr score less than V, equating to the
ability to walk independently (with or without an assist-
ive device); Mini Mental State Examination score [17] of
24 or greater; ability to participate safely in an exercise
program and to provide informed consent. Caregivers
were included in the current study if they were nomi-
nated as the main caregiver by the person with PD, were
willing to provide informed consent, and were able to
read and complete the necessary questionnaires.
Procedure
Information from care-recipients was collected as part
of the baseline assessment protocol of the larger study
[16], performed by trained physical therapists in an out-
patient setting. Caregiver assessments were performed at
the same time if they had accompanied their care-
recipient, or by postal completion of questionnaires.
Outcome measures
Health related quality of life
The EuroQoL (EQ-5D) was chosen as the common
HRQoL tool for both people with PD and their care-
givers [18]. It utilises five questions covering mobility,
personal care, usual activities, pain / discomfort and
anxiety / depression, each with three options and sum-
ming to a single score. The overall health state is subse-
quently defined by a five-digit number. Comparisons
with healthy older people and other patient groups are
available [18]. A Visual Analogue Scale (VAS) is
included, depicting the subject’s perceived health on a
scale of 0 (death) – 100 (perfect health) on that day. The
EQ-5D is sensitive to the clinical features of the Parkin-
son’s Disease Questionnaire-39 (PDQ-39) [19] and cor-
relates strongly with both PDQ-39 and Hoehn and Yahr
scores [20]. Country specific weightings have been devel-
oped for the EQ-5D which reflect the respective popula-
tion data of the country from which they have been
derived. As no Australian weights (Wt) are available, the
VAS and time trade off (TTO) weighted scores were cal-
culated using the United Kingdom weights and formulae
as described by Szende et al. [21].
The disease-specific PDQ-39 [22] was also used to
evaluate HRQoL in the participants with PD. The PDQ-
39 uses 39 questions with five levels of choice and covers
eight domains, including mobility, activities of daily liv-
ing and emotional well-being. These are weighted to
provide a single score, with higher scores denoting lower
HRQoL. The PDQ-39’s strong measurement qualities
[11] make it the most widely used disease-specific tool
in Parkinson’s disease.
Caregiver Strain
Caregiver strain or enduring change in wellbeing was
evaluated using the Modified Caregiver Strain Index
(MCSI) [23,24]. This instrument uses 13 questions
scored at three levels to assess the impact of caring on
the provider’s health, finances, social interactions, time
demands and employment. Scores from 0 to 2 for each
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question lead to a maximum of 26, denoting maximal
strain.
Other measures
Motor performance in participants with PD was assessed
by the timed 6-metre walk test (6MWT), which has
demonstrated reliability in people with PD [25]. The
modified Hoehn and Yahr scale [26] was used to provide
an overall view of the level of PD severity, where I
denotes mild unilateral symptoms progressing to an in-
ability to walk at level V.
Statistical analysis
Descriptive data were summed and tabulated. As scoring
on the EQ-5D, PDQ-39 and MCSI is ordinal, the non-
parametric Spearman rank correlations coefficient (rs)
was used to examine associations between measures. All
analyses were performed using PASW Statistics 18.0
(SPSS) and IBM SPSS Statistics 19.0.
Results
The primary RCT included 210 people with PD, with
data for the current study available from 97 caregiver–
recipient dyads. Seven missing data points in PDQ-39
(0.15% of data) were filled using the expectation
minimization algorithm [27].
Participant Characteristics
Participants with PD were predominantly men (64%) in
their late 60s (Table 1). There was a spread of disease se-
verity as measured by the modified Hoehn and Yahr sta-
tus [26] with the largest number (54%) moderately
disabled at level 3 and above. A further 32% were classi-
fied as level 2 or 2.5. Although only two percent
required supported accommodation, the higher number
with moderate to severe disease suggests considerable
demands on some caregivers, as carer strain is known to
increase with Hoehn and Yahr level [28].
Most caregivers (84%) were spouses/partners, with
13% being their children. Sixty-six percent of caregivers
were over 60 years old, seven percent were over 80 and
six percent were less than 40 years old.
HRQoL in PwPD and their caregivers and caregiver strain
HRQoL scores in both people with PD and their care-
givers using the EQ-5D VAS were negatively skewed,
suggesting that this Australian sample had relatively
good HRQoL. The mean EQ-5D VAS score for the parti-
cipants with PD was 72 (SD= 16) ranging from a low of
15 to the maximum score of 100, with a median of 73
and interquartile range of 25 (60–85). This score was, as
expected, lower than the caregivers’ mean of 83 (SD= 13),
ranging from 50 to 100, with a median of 85 and inter-
quartile range 16 (77–93); Mann Whitney U: p< 0.001.
The results of TTO and VAS Wt components of the
EQ-5D essentially reflected the VAS scores. The level of
caregiver strain reflected by MCSI scores was similarly
somewhat low, with most caregivers scoring less than
16 out of a maximum 26 (median= 5, inter-quartile
range = 8, range 0–25). Despite the low median, some
caregivers were at near-maximal strain.
Association between HRQoL in caregiver and care-
recipient
As expected, HRQoL scores using the EQ-5D VAS were
lower in participants with PD (mean = 72.1, SD= 16.4;
range 15–100). Similar distributions were shown using
the EQ-5D TTO and VAS Wt methods. No significant
correlations were found between HRQoL in caregiver
and care-recipient, whether using the generic EQ-5D for
PD, or the disease-specific PDQ-39 (See Figure 1).
HRQoL in this sample of caregivers and care-recipients
was not related.
Association between caregiver HRQoL and caregiver
strain
No significant correlation was found between caregiver
strain and caregiver HRQoL irrespective of the measure
used (EQ-5D VAS: rs =−0.13, p= 0.11; TTO: rs =−0.08,
p= 0.21; VAS Wt: rs =−0.09, p= 0.19). Most caregivers
reported relatively low levels of strain (13 or less),
coupled with relatively high HRQoL of 75 or more. Of
interest, there was no significant correlation between
caregiver strain and caregiver age (rs =−0.15, p = 0.079).
Association between HRQoL in PwPD and caregiver strain
Both the EQ-5D and PDQ-39 were used to evaluate the
association between HRQoL in the participants with PD
and the level of strain experienced by their caregivers (as
indicated by MCSI scores). A small but significant
Table 1 Characteristics of participants with PD
Participant characteristics PwPD (n = 97)
Age (years); mean (SD) 68.5 (9.5)
Gender, n females (%) 35 (36)
Disease duration (years); mean (SD) 7.5 (5.8)
Modified Hoehn and Yahr stage; n (%)






Timed 6 Metre Walk Test a (seconds); mean (SD) 5.8 (2.1)
a Two participants with missing data.
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negative relationship was found using the EQ-5D TTO
and VAS Wt, but not the unweighted VAS (see Table 2),
suggesting that poorer HRQoL in people with PD is
associated with higher caregiver strain experienced by
their caregivers. This became more obvious when the
disease-specific PDQ-39 scores were used. The correl-
ation of PDQ-39 with MCSI scores (rs = 0.3 at p< .001)
confirmed that poorer self-rated health in people with
PD was associated with increased strain in their
caregivers.
Discussion
This study is one of the first on HRQoL and caregiver
strain in an Australian sample of people caring for fam-
ily members with PD. By comparison with the literature,
both the caregivers and the care-recipients in our sample
demonstrated relatively high levels of HRQoL, although
that of the people with PD was, as expected, somewhat
lower than their caregivers. Previous studies have
reported reduced HRQoL in groups of people with PD
of similar age and disease duration [29,30] when using
the EQ-5D VAS. Others have noted greater emotional
distress [31] and increased rates of depression in care-
givers of people with PD [5,32], findings that suggest
caregiver HRQoL may also be reduced. In the current
study, however, the mean EQ-5D VAS scores in our
cohort of caregivers were similar to non-caregiving Aus-
tralians of comparable age [33]. Further, it appeared that
caregivers in our sample had higher scores for HRQoL
than cohorts in the Netherlands [15,34], Spain [10,35]
and the UK [36,37]. However, as the Australian value
was within one standard deviation of other results, this
difference should be interpreted with caution.
Unlike previous studies [4,38], we failed to find an as-
sociation between HRQoL in the caregiver and care-
recipient. Although Martinez-Martin et al.’s sample was
similar to ours in age and mean Hoehn and Yahr status,
they used different assessment tools for caregiver
HRQoL (the caregiver-specific SQLC: Scale of Quality of
Life of Caregivers [39]) and care-recipient HRQoL (EQ-
5D [18] and PDQ-8 [40]). The slightly different domains
covered potentially impact on attempted comparisons
across groups. Differences in culture or facilities between
Spain and Australia may also affect the HRQoL of care-
giver or of the people with PD. Peters et al. [38] found a
moderate correlation in HRQoL between the mental
component score of this measure in people with PD and
their caregivers in their UK sample of> 700 dyads using
the SF12 [41]. Despite using the same instrument for
both groups, differences between their cohort and ours
may explain why they found a relationship between the
two. The Peters et al. cohort was similar in age but may
have had more long-standing disease; 35% of patients
had been diagnosed for five to ten years and 32% for
longer than 10 years, whereas the mean disease duration
for our participants was 7.5 years. Another potential dif-
ference lies in the fact that the EQ-5D captures informa-
tion about how people perceive their HRQoL at that
time, whereas the SF-12 and PDQ-39 ask about percep-
tions over the past four weeks. This may lead to under-
reporting from the EQ-5D.
Figure 1 Correlations between HRQoL in care-givers and care-recipients with PD. CG= caregiver, PD= care-recipient with Parkinson’s
disease.
Table 2 Relationship between measures of HRQoL in
people with PD and care-giver strain (MCSI)
Correlated variables Spearman rho p value
PD EQ-5D VAS −0.16 0.061
PD EQ-5D VAS Wt −0.20 0.025
PD EQ-5D TTO −0.18 0.042
PD PDQ-39 0.43 0.001
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Contrary to expectations, no relationship was found
between caregiver HRQoL and caregiver strain, perhaps
related to the relatively high HRQoL and low levels of
strain reported by our cohort. As more than half of our
caregivers reported optimal health, the impact of a ceil-
ing effect to the EQ-5D cannot be discounted. An Aus-
tralian study found a strong tendency of the EQ-5D to
allocate an excess of responses a 1.00 value and there-
fore reduce the capacity of the instrument to discrimin-
ate at the upper end of the range [33]. Although MCSI
scores were more evenly distributed, some 80% of care-
givers reported scores in the lower half of the scale,
meaning relatively low levels of strain. At the individual
level however, some caregivers reported near-maximal
strain, reinforcing the potential of extreme strain in fam-
ily caregivers.
In comparison with the literature there were no stud-
ies found examining the relationship between caregiver
strain using the MCSI with caregiver HRQOL. While
there have been several which have examined its precur-
sor, the Caregiver Strain Index (CSI), correlations were
not reported [37,41]. However several studies have found
a statistically significant negative correlation between the
Caregiver Burden Index (CBI) and caregiver HRQOL
(SQLC) [5,42], whilst another has found a significant
negative association with the Zarit Caregiver Burden In-
ventory (ZCBI) [32].
Our findings of reasonable HRQoL and fairly low care-
giver strain may relate to the nature of our sample. De-
pression is the most commonly cited predictor of
reduced HRQoL in people with PD [43] and known to
have a negative impact on caregiver HRQoL [44] and
stress, strain or burden [31,44]. People with depression,
whether patient or caregiver, may be less willing to par-
ticipate in a research project, especially when the major
study required 14 months commitment from partici-
pants. Further, dementia was an exclusion criterion
(MMSE score of less than 24), potentially contributing
to selection bias because cognitive issues in the care-
recipient are known to increase caregiver burden [5] and
distress [31].
Our group of caregivers was under less strain than has
been reported in other papers, perhaps because of rela-
tively higher HRQoL. For example, Peters et al. [38]
reported a mean of 11.89 (SD 6.39) (maximum possible
for maximal strain is 26 points) on the MCSI, whereas
the median for our caregivers was only 5. This may re-
flect a longer disease duration and considerably poorer
HRQoL of their Parkinson’s group (mean PDQ-39 index
score of 41 (SD 18), compared to 23 (SD 12) for the par-
ticipants with PD in our study).
In support of the idea that better HRQoL in care-
recipients reduces strain on the caregiver, a significant
correlation existed between the HRQoL in the
individuals with PD and the level of strain experienced
by their caregivers. Greater correlations were found
using the disease-specific PDQ-39 than the generic EQ-
5D measure. The added strength of the PDQ-39 correl-
ation is not surprising, given that it is disease-specific,
comprises 39 detailed items, and evaluates HRQoL over
the past four weeks, rather than a single day as in the
EQ-5D. Peters et al [38] similarly reported higher corre-
lations between the PDQ-39 and MCSI (rs = 0.56,
p< .001) than the generic SF-12 in care-recipients and
the MCSI (physical component: rs =−0.33; p< .001;
mental component: rs =−0.41, p< .001 [note that SF-12
and MCSI are scored in different directions, leading to
negative correlations]).
Understanding the direct impact of patient HRQoL on
the levels of caregiver strain is an important result. It
has been suggested that families are “the most valuable
and also the most vulnerable resource” in the treatment
of PD [28]. Recognition of this has led to the develop-
ment of educational and support programs for family
caregivers of people with PD [15,34]. It also suggests
that HRQoL should be a routine part of the assessment
of patients with PD by health professionals, in conjunc-
tion with caregiver strain. Results from the PDQ-39 can
inform the treating staff about how important various
problems are to the individual, enabling management to
be directed towards what is important to the patient, ra-
ther than most obvious to the therapist. PDQ-39 items
such as difficulties dressing, carrying shopping or getting
around the home, can be improved with targeted inter-
vention by physical therapists, occupational therapists or
nurses. Prioritising treatment by patient perceptions of
difficulty provides emotional as well as physical benefits
as the people with PD feels “listened to” and their opin-
ion valued. Improved HRQoL of the care recipients may
then flow on to help minimise caregiver strain.
Limitations
The cross sectional design, appropriate for the aims of
the study, meant that issues of causality between vari-
ables could not be investigated. A further limitation of
this study is that depression was not measured. Depres-
sion is a notable factor that contributes to the HRQOL
and caregiver strain [9,28,31,32,45] although it was be-
yond the scope of this study to include measures of de-
pression. Similarly, other pertinent caregiver personal
factors that may influence strain and HRQOL such as
sense of coherence, coping styles and resilience were not
examined. The above factors could be explored in future
research on caregiver quality of life and caregiver strain.
This sample cannot be taken to be completely repre-
sentative of all caregivers. The sample was one of con-
venience with ambulant clients who had volunteered. It
is possible that volunteers with PD and their caregivers
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who were not overly burdened by their condition could
have been more likely to volunteer, or the responses of
caregivers may have been in a more positive direction
than for the broader community of caregivers of people
with PD. Nevertheless, the sampling methods were simi-
lar to most other studies which examined the HRQOL
of caregivers throughout the world.
Conclusions
This sample of Australians with PD and their caregivers
experienced relatively good HRQoL and there was a
generally low level of caregiver strain. However, poorer
HRQoL in people with PD was significantly associated
with increased strain in caregivers. Assessment of
HRQoL may enable targeted interventions that may in-
directly reduce caregiver strain.
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